The authors showed that IFNλ3 predicted subsequent oxygen demand better than other humoral factors (e.g., CRP, LDH, lymphocyte fraction) in patients in the early phase of COVID‐19 without supplemental oxygen demand. The gene discussed is IFNL3; the disease is COVID-19.